Articles From: TECH STOCKS: GoPro Gains Stand Out In Tech's Advance to CTC Media Announces Staff Changes


By Rex Crum, MarketWatch Digital-camera maker rises after plans for secondary stock offering SAN FRANCISCO (MarketWatch) -- Tech stocks put in a strong performance Tuesday, with GoPro Inc. among the advancers even after the digital-camera maker and several big shareholders filed to sell more than 10 million shares of the company's stock.
Sign-up for TECH STOCKS: GoPro Gains Stand Out In Tech's Advance investment picks
By Rex Crum, MarketWatch Digital-camera maker rises after plans for secondary stock offering SAN FRANCISCO (MarketWatch) -- Tech stocks put in a strong performance Tuesday, with GoPro Inc. among the advancers even after the digital-camera maker and several big shareholders filed to sell more than 10 million shares of the company's stock.
Sign-up for GoPro gains stand out in tech's advance investment picks
At an Analyst Day event held earlier today in New York City, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reviewed the financial leverage in its business model, revenue growth opportunities and its portfolio of partnered assets and unpartnered development programs, as well as its Captisol formulation technology and its financial outlook through 2017.
Sign-up for Ligand Provides Highlights from Today’s Analyst Day Event investment picks
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that Thomas J.
Sign-up for Span-America to Nominate Thomas J. Sullivan to Board of Directors investment picks
Seagate Technology plc (NASDAQ: STX), a world leader in storage solutions, today announced that as part of its continued commitment to open source communities, the contribution of an Apache Hadoop on Lustre ® Connector.
Sign-up for Seagate Demonstrates Open Source Commitment investment picks
SCOTTSDALE, Ariz., Nov.
Sign-up for Kona Grill Opens in Columbus, Ohio investment picks
2014/11/18
Corus Entertainment Announces Development Slate of Corus-Owned Original Unscripted Reality Series Canada NewsWire TORONTO , Nov.
Sign-up for Corus Entertainment Announces Development Slate of Corus-Owned Original Unscripted Reality Series investment picks
2014/11/18
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a class action lawsuit has been filed against Pacira Pharmaceuticals, Inc. (“Pacira” or “Company”) (NasdaqGS: PCRX) and several officers and directors for acts taken during the period of April 9, 2012 to September 24, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Pacira.
Sign-up for Pacira Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
2014/11/18
By Alexander Kolyandr MOSCOW--Russian fertilizer giant Uralkali (URKA.MZ) said on Tuesday that it has suspended work at one of its mines due to higher levels of brine.
Sign-up for Uralkali Suspends Work at Mine investment picks
2014/11/18
- Former Director of the NIH Vaccine Research Center to Spearhead Sanofi Efforts, and Contribution to Global Fight against Ebola - PARIS , Nov.
Sign-up for Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator investment picks
2014/11/18
- Researcher says Texas' diversification implies less severe risk scenario than 1980s - Bank economist suggests a moderate-to-mild impact in state's major markets, including Houston HOUSTON , Nov.
Sign-up for Texas economy equipped to deal if oil prices collapse, BBVA Compass economist says investment picks
2014/11/18
Yahoo Mail is experiencing temporary site outages.
Sign-up for Yahoo Mail down for some customers investment picks
2014/11/18
By William Boston BERLIN--The rate of recovery for car sales in the European Union is accelerating toward the end of 2014, suggesting that growth after six years of decline could be stronger than expected.
Sign-up for EU Car Sales Gain Pace for Second Straight Month - Update investment picks
CLEVELAND , Nov.
Sign-up for KeyCorp To Present At The 2014 Goldman Sachs US Financial Services Conference investment picks
2014/11/18
GREENVILLE, S.C., Nov.
Sign-up for All Med Goes Live on eRAD PACS investment picks
2014/11/18
What : Plant Farley, in cooperation with state and local emergency management agencies, will conduct a test of the plant's emergency siren system to ensure residents can be promptly notified in the unlikely event of a plant emergency and to comply with Federal Emergency Management Agency regulations.
Sign-up for Plant Farley to conduct siren testing; sirens will be heard in communities surrounding the plant investment picks
2014/11/18
By Alex MacDonald LONDON--
Sign-up for AstraZeneca Bets Long Term on Cancer Drugs -- 2nd Update investment picks
New Agreement Expands VOXX's Car Connection Program HAUPPAUGE, N.Y. , Nov.
Sign-up for VOXX Electronics Corporation and AT&T Sign International Data Agreement investment picks
Company Plans to Use IPO Proceeds to Reduce Debt RALEIGH, N.C. , Nov.
Sign-up for PRA Health Sciences, Inc. Announces Successful Closing of its Initial Public Offering investment picks
Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has enhanced its PAT series of AEC-Q200-qualified precision automotive thin film chip resistors with an extended resistance range from 2.5 Ω to 3 MΩ.
Sign-up for Vishay Intertechnology Extends Resistance Range of AEC-Q200-Qualified PAT Automotive Thin Film Chip Resistors investment picks
Data was presented at the American Heart Association meeting in Chicago on November 17, 2014 regarding the safety and feasibility of Cytori Cell Therapy using Adipose Derived Regenerative Cells (ADRCs™) administered through the coronary artery in patients with acute ST segment elevated myocardial infarction from the ADVANCE clinical trial sponsored by Cytori Therapeutics, Inc. (NASDAQ: CYTX). The ADVANCE clinical trial sought to define the safety, feasibility and efficacy of an intracoronary infusion of ADRCs in patients admitted with an acute ST-elevation myocardial infarction (STEMI) within 24 hours of successful primary percutaneous coronary intervention (PCI). In this randomized, double-blind, placebo-controlled trial (n=23, 2:1 randomization), within 24 hours of successful primary PCI following STEMI, a small volume liposuction was performed for fat harvest and ADRC
Sign-up for Safety and Feasibility of Cytori Cell Therapy in Acute Myocardial Infarction Presented at 2014 American Heart Association Meeting investment picks
2014/11/18
SAN DIEGO, Nov.
Sign-up for The UPS Store: Packing and Delivering Holiday Happiness investment picks
MOSCOW, Nov.
Sign-up for CTC Media Announces Staff Changes investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: TECH STOCKS: GoPro Gains Stand Out In Tech's Advance to CTC Media Announces Staff Changes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent